Purpose: To catalog ophthalmic findings in a cohort of patients with s
cleromyxedema. Methods: Thirty-five biopsy-proven patients with sclero
myxedema evaluated at the Mayo Clinic in Rochester, Minnesota, from 19
60 to 1991 were identified. Eye examinations were performed on 17 of t
he patients. Ophthalmic findings not attributable to other systemic or
ocular disease were recorded. Results: The following abnormalities we
re considered secondary to scleromyxedema: corneal opacities (2 patien
ts), thickened eyebrow or eyelid skin (4 patients), lagophthalmos (1 p
atient), and ectropion (2 patients). One patient who had concurrent po
lyneuropathy, organomegaly, endocrinopathy, monoclonal gammopathy, and
skin changes (POEMS) syndrome also had choroidal folds and papilledem
a. A corneal biopsy in one patient disclosed deposits of acid mucopoly
saccharide, consistent with one of two previously published cases. Con
clusion: A series of patients with scleromyxedema was reviewed. This s
ystemic disorder infrequently may cause visually significant ophthalmi
c manifestations, including eyelid changes and corneal deposits. Furth
er study is needed to characterize better the nature of the corneal op
acities.